NCT03140839

Treating Negative Mental Images and Memories in Social Anxiety

Completed NA Last updated 16 January 2019

What this trial tests

NA trial testing Imaginal Rescripting in Social Anxiety in 33 participants. Completed in 23 August 2018.

Timeline

10 May 2017

Primary endpoint
23 August 2018

23 August 2018

Quick facts

Lead sponsor	University of Waterloo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	33
Start date	10 May 2017
Primary completion	23 August 2018
Estimated completion	23 August 2018
Sites	1 location across Canada

Drugs / interventions tested

• Imaginal Rescripting
• Imaginal Exposure
• Supportive Counselling

Conditions studied

• Social Anxiety — all drugs for Social Anxiety →

Sponsor

University of Waterloo

Who can join

Eligibility, any sex, with Social Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed research will study the effects of Imaginal Rescripting (IR) for social anxiety disorder (SAD). IR guides patients to change their memories of past socially painful events. Initial studies have found that a single session of IR significantly reduces SAD symptoms, however it is not yet clear how or why IR works and whether its effects are long lasting. To answer these questions, the investigators will randomly assign adults with SAD to receive either IR, or two other types of brief psychological interventions: Imaginal Exposure and Supportive Counselling. Changes in participants' memories, social anxiety symptoms, quality of life, negative beliefs, and social behaviour over the course of a 6-month period will be assessed. This study will provide valuable insight into the short- and long-term effects of IR and clarify the mechanisms through which IR works. Ultimately, this knowledge will enable the development of more effective treatments and prevention programs for SAD.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.